Trial Profile
A 32-week National, Single-centre, Open-labelled, Randomised, Crossover Trial Comparing Energy Expenditure With Insulin Detemir Versus NPH Insulin Using a Basal-Bolus Regimen With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin aspart; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 09 Jul 2012 Additional trial location (Europe) added as reported by ClinicalTrials.gov.
- 20 Sep 2010 Results of a secondary endpoint were presented at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 06 Jul 2010 Additional lead trial investigator identified as reported by ClinicalTrials.gov.